Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Medtronic
Accenture
Johnson and Johnson
Fish and Richardson
Covington
Colorcon
McKinsey
Moodys

Generated: January 21, 2019

DrugPatentWatch Database Preview

Glenmark Generics Company Profile

« Back to Dashboard

What is the competitive landscape for GLENMARK GENERICS, and what generic and branded alternatives to GLENMARK GENERICS drugs are available?

GLENMARK GENERICS has sixty-eight approved drugs.

There are three tentative approvals on GLENMARK GENERICS drugs.

Summary for Glenmark Generics
US Patents:0
Tradenames:59
Ingredients:54
NDAs:68
Patent Litigation for Glenmark Generics: See patent lawsuits for Glenmark Generics

Drugs and US Patents for Glenmark Generics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 090135-006 Feb 25, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics ALYACEN 1/35 ethinyl estradiol; norethindrone TABLET;ORAL-28 091634-001 Jan 19, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics MOMETASONE FUROATE mometasone furoate CREAM;TOPICAL 078541-001 May 28, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics NAPROXEN naproxen TABLET;ORAL 078250-003 Mar 28, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 090135-002 Feb 25, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics MONTELUKAST SODIUM montelukast sodium TABLET;ORAL 090926-001 Aug 3, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091575-001 Aug 13, 2010 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for GLENMARK GENERICS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Fish and Richardson
Harvard Business School
US Department of Justice
Mallinckrodt
Colorcon
Queensland Health
UBS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.